ANDA 74943, held by Apotex. Diltiazem Hydrochloride.
As of Nov 16, 2026, ANDA 74943 (Diltiazem Hydrochloride), held by Apotex, was first approved by FDA on Aug 6, 1998, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 6, 1998 | Original application | Approved |
| Diltiazem Hydrochloride240MG ยท capsule, extended release;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride180MG ยท capsule, extended release;oral | Diltiazem Hydrochloride | Rx |
| Diltiazem Hydrochloride120MG ยท capsule, extended release;oral | Diltiazem Hydrochloride | Rx |
| Aug 25, 2015 | Supplement 14Labeling ยท Standard review | Approved | None posted |
| Jan 20, 2011 | Supplement 12Labeling | Approved | None posted |
| Apr 12, 2007 | Supplement 7Manufacturing | Approved | None posted |
| Jul 26, 2005 | Supplement 6Labeling | Approved | None posted |
| Mar 22, 2002 | Supplement 3Manufacturing | Approved | None posted |
| Mar 22, 2002 | Supplement 4Labeling | Approved | None posted |
| Dec 19, 2000 | Supplement 1Manufacturing | Approved | None posted |
| Dec 19, 2000 | Supplement 2Labeling | Approved | None posted |
| Aug 6, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters